Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Pinto

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Clinical Genitourinary Cancer|July 23, 2014
Adjuvant therapy for renal cell carcinomaAlvaro Pinto
Cancer Chemotherapy and Pharmacology|November 9, 2013
Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinomaAlvaro Pinto
Drugs in R&D|November 30, 2012
Radium-223 chloride: a new treatment option for metastatic castration-resistant prostate carcinomaAlvaro Pinto, Patricia Cruz
World Journal of Clinical Oncology|August 28, 2024
Potential role of transmembrane 9 superfamily member 1 as a biomarker in urothelial cancerAlvaro Pinto, Abrahams Ocanto, Felipe Couñago
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 1, 2006
Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropeniaCésar Gómez Raposo, Alvaro Pinto Marín, Manuel González Barón
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2005
Sedation in clinical oncologyManuel González Barón, César Gómez Raposo, Alvaro Pinto Marín
Anti-Cancer Drugs|August 24, 2010
Angiogenesis as a therapeutic target in urothelial carcinomaAlvaro Pinto, Andrés Redondo, Pilar Zamora, et al.
Tumori|February 24, 2015
Prolonged response to aflibercept in ovarian cancer relapse: a case reportAndrés Redondo, Beatriz Castelo, Alvaro Pinto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 1, 2008
Primary cardiac osteosarcomaMaría López, Alvaro Pinto, Víctor Moreno, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 29, 2011
Targeting the endothelin axis in prostate carcinomaAlvaro Pinto, María Merino, Pilar Zamora, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Clinical Genitourinary Cancer|July 23, 2014
Adjuvant therapy for renal cell carcinomaAlvaro Pinto
Cancer Chemotherapy and Pharmacology|November 9, 2013
Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinomaAlvaro Pinto
Drugs in R&D|November 30, 2012
Radium-223 chloride: a new treatment option for metastatic castration-resistant prostate carcinomaAlvaro Pinto, Patricia Cruz
World Journal of Clinical Oncology|August 28, 2024
Potential role of transmembrane 9 superfamily member 1 as a biomarker in urothelial cancerAlvaro Pinto, Abrahams Ocanto, Felipe Couñago
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 1, 2006
Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropeniaCésar Gómez Raposo, Alvaro Pinto Marín, Manuel González Barón
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 28, 2005
Sedation in clinical oncologyManuel González Barón, César Gómez Raposo, Alvaro Pinto Marín
Anti-Cancer Drugs|August 24, 2010
Angiogenesis as a therapeutic target in urothelial carcinomaAlvaro Pinto, Andrés Redondo, Pilar Zamora, et al.
Tumori|February 24, 2015
Prolonged response to aflibercept in ovarian cancer relapse: a case reportAndrés Redondo, Beatriz Castelo, Alvaro Pinto, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 1, 2008
Primary cardiac osteosarcomaMaría López, Alvaro Pinto, Víctor Moreno, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 29, 2011
Targeting the endothelin axis in prostate carcinomaAlvaro Pinto, María Merino, Pilar Zamora, et al.
Pageof 6